MORE►
Verily Health
Fort Worth-based Nacuity Pharmaceuticals won a patent this week for a method of treating retinitis pigmentosa with an oral antioxidant drug. This illustration shows pigment deposits in the retina, a sign of the genetic eye disease. [Illustration: AdobeStock]
Patented: Nacuity’s Vision-Loss Drug Method and 124 More Inventions Across North Texas
by Dave Head | Jul 29, 2026
Dallas-Fort Worth ranked No. 9 for patent activity out of 250 metros for the week of June 30 with a total of 125 patents granted.
by Sandra Engelland |
Mar 24, 2026
Verily graduated from Google X 10 years ago as one of Alphabet’s earliest “Other Bets," focusing on breakthrough science and health tech innovation. Its new round was led by Series X Capital, with participation from Alphabet, UCHealth, the University of Colorado Anschutz, and other investors.
MORE►
